Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ).
Shandong Xinhua Pharmaceutical Company Limited has announced the receipt of a Drug Registration Certificate for its Ibuprofen Suspension Drops from the National Medical Products Administration. This approval allows the product to be marketed as an over-the-counter drug, potentially enhancing the company’s market presence in the pharmaceutical industry.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, primarily engaged in the production and sale of pharmaceutical products. The company focuses on the development and distribution of over-the-counter drugs, with a particular emphasis on chemical pharmaceuticals.
Average Trading Volume: 4,104,058
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$9.7B
For a thorough assessment of 0719 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue